Corneal Edema
Evidence-based clinical reference for corneal edema — the pathological accumulation of fluid within corneal stroma and epithelium resulting from endothelial pump failure or epithelial barrier disruption. Covers Fuchs dystrophy, pseudophakic bullous keratopathy, contact lens-induced edema, and the full spectrum from microcystic changes to bullous keratopathy.
Last updated: March 2026
Corneal edema is the pathological accumulation of fluid within the corneal stroma and/or epithelium, resulting in loss of the normal corneal transparency that is essential for high-quality vision. The cornea maintains its transparency and relative dehydration through the active fluid-pumping function of the corneal endothelium — a monolayer of cells that cannot regenerate in humans. When endothelial cell density falls below a critical threshold (approximately 400–500 cells/mm²), the pump mechanism fails and corneal edema ensues.
Corneal edema is broadly divided into epithelial edema (fluid within and beneath the epithelial layer, forming microcysts and bullae) and stromal edema (fluid between stromal lamellae, causing haze and Descemet folds). In clinical practice, both often coexist in advanced disease. The spectrum ranges from transient contact lens-induced oedema to permanent visual disability from bullous keratopathy requiring corneal transplantation.
The leading causes in optometric practice are Fuchs endothelial corneal dystrophy, pseudophakic bullous keratopathy (PBK) following intraocular surgery, and contact lens-induced chronic hypoxia. Early recognition and appropriate referral are critical to preserve vision and quality of life.
Endothelial Cell Loss (Primary)
- Fuchs endothelial corneal dystrophy (FECD): autosomal dominant degeneration with progressive guttata formation and endothelial cell loss; the most common cause of corneal edema in adults over 50
- Posterior polymorphous corneal dystrophy (PPCD): rare hereditary endothelial disorder causing abnormal endothelial cell morphology and varying degrees of edema
- Congenital hereditary endothelial dystrophy (CHED): bilateral corneal oedema present at birth or early infancy from absent or dysfunctional endothelium
- Iridocorneal endothelial syndrome (ICE): unilateral acquired endothelial disease with abnormal cell migration and secondary angle closure glaucoma
Surgical and Iatrogenic
- Pseudophakic / aphakic bullous keratopathy: endothelial damage from cataract surgery (phacoemulsification ultrasound energy, IOL touch, viscoelastic toxicity); historically the most common indication for penetrating keratoplasty
- Anterior chamber IOL (ACIOL) touch: chronic mechanical endothelial trauma from a poorly positioned anterior chamber or iris-fixated IOL
- Glaucoma surgery: tube shunt or trabeculectomy bleb-related endothelial touch; misdirected aqueous; prolonged hypotony
- Endothelial keratoplasty (DSAEK/DMEK) failure: primary graft failure or late immune rejection
- Corneal transplant rejection: endothelial rejection after penetrating keratoplasty (PKP) is the leading cause of graft failure
Elevated Intraocular Pressure
Acute angle closure glaucoma produces rapid, severe IOP elevation that overwhelms endothelial pump capacity, causing acute corneal edema with stromal haze and epithelial microcysts. Chronically elevated IOP in decompensated open-angle glaucoma may contribute to accelerated endothelial cell loss over time.
Contact Lens–Related
Extended wear of low-oxygen-transmissibility (Dk/t) contact lenses reduces corneal oxygen tension, impairing endothelial pump activity and producing stromal edema — historically termed "corneal exhaustion syndrome." Modern high-Dk silicone hydrogel lenses have substantially reduced but not eliminated this risk. Overnight wear remains the major modifiable risk factor.
Inflammatory and Infectious
- Herpetic keratouveitis (HSV, HZV) — endothelial inflammation (keratouveitis) and direct endotheliitis
- Anterior uveitis — inflammatory mediators impair endothelial pump; raised IOP from trabeculitis
- Bacterial / fungal keratitis — toxin-mediated or direct endothelial damage in deep ulcers
- Acanthamoeba keratitis — stromal inflammation can extend to endothelium in severe cases
Toxic and Chemical
- Preserved topical medications (benzalkonium chloride) — chronic toxicity to endothelial cells
- Chemical ocular injuries (acid/alkali) — direct destruction of endothelium
- Intracameral injection of wrong concentration / agent during surgery
Normal Corneal Dehydration Mechanisms
The cornea is maintained in a state of relative dehydration (78% water content) by two complementary mechanisms. The epithelial barrier prevents tear film water from entering the stroma. The endothelial fluid pump — driven by Na⁺/K⁺-ATPase and bicarbonate-dependent ATPase in endothelial cells — continuously transports fluid from stroma to aqueous humor against an osmotic gradient, counteracting the imbibition pressure of the hydrophilic stromal proteoglycans.
Endothelial Pump Failure
Human corneal endothelial cells do not replicate under normal physiological conditions. The normal adult density is 2,500–3,000 cells/mm². As cells are lost to disease, ageing (approximately 0.6% per year), or trauma, remaining cells enlarge (polymegethism) and assume irregular shapes (pleomorphism) to maintain coverage. When density falls below approximately 400–500 cells/mm², the pump cannot maintain stromal dehydration and corneal edema develops progressively:
- Stromal edema: fluid first accumulates between collagen lamellae, increasing corneal thickness and disrupting the regular lamellar spacing required for transparency, producing light scatter (haze)
- Descemet membrane folds: excess fluid causes mechanical distortion of the Descemet membrane, creating the characteristic folds visible on slit-lamp retroillumination
- Epithelial edema: fluid progressively moves anteriorly, accumulating in the basal epithelial cell layer as microcysts, then coalescing into larger intraepithelial and subepithelial fluid collections (bullae)
- Bullous keratopathy: large epithelial bullae rupture, exposing bare nerve endings and causing acute severe pain; repeated cycles of bulla formation and rupture lead to subepithelial fibrosis
Epithelial Barrier Disruption
In contact lens hypoxia, reduced oxygen supply impairs epithelial tight junctions and increases epithelial permeability, allowing fluid to enter the stroma. Stromal lactate accumulation from anaerobic metabolism raises osmolarity, drawing additional water in. This mechanism is fully reversible on contact lens removal.
IOP-Mediated Edema
In acute angle closure, IOP elevation to 40–70 mmHg exceeds the endothelial pump capacity (which normally operates against aqueous pressure of ~15 mmHg), causing fluid to enter the stroma rapidly. Epithelial microcysts develop within hours of IOP elevation above 40 mmHg. Prompt IOP lowering reverses this edema completely if endothelial cells have not been irreversibly damaged.
By Anatomical Layer
| Type | Location | Slit-lamp Finding | Typical Cause |
|---|---|---|---|
| Epithelial | Intraepithelial / subepithelial | Microcysts, bullae, irregular reflex | CL hypoxia, advanced FECD, PBK |
| Stromal | Lamellar stroma | Haze, Descemet folds, increased pachymetry | Endothelial failure, acute AAC, keratitis |
| Combined | Epithelium + stroma | Haze + bullae + Descemet folds | Advanced FECD, PBK, chemical injury |
Grading of Corneal Edema (Clinical)
| Grade | Description | Corneal Thickness | Visual Impact |
|---|---|---|---|
| Trace | Subtle stromal haze; Descemet folds only on retroillumination | 540–580 µm | Minimal; glare in bright light |
| Mild | Visible stromal haze; epithelial microcysts; morning blurring | 580–620 µm | Reduced BCVA; fluctuating |
| Moderate | Marked haze; small bullae; significant Descemet folds | 620–700 µm | VA 6/12–6/36; glare, halos |
| Severe | Dense haze; large bullae; subepithelial fibrosis; vascularisation | >700 µm | VA <6/60; severe pain from rupture |
By Aetiology (Clinical Categories)
- Dystrophic: Fuchs FECD, PPCD, CHED, ICE syndrome
- Postoperative / iatrogenic: pseudophakic/aphakic bullous keratopathy, graft failure
- Inflammatory / infectious: herpetic endotheliitis, uveitic, keratitis
- Pressure-induced: acute angle closure, decompensated glaucoma
- Hypoxic: contact lens-related
- Toxic/chemical: drug toxicity, chemical injury
Genetic / Hereditary
- Family history of Fuchs endothelial dystrophy (autosomal dominant; SLC4A11, TCF4 mutations)
- Female sex (FECD is 3× more common in women)
- Posterior polymorphous corneal dystrophy
- Congenital hereditary endothelial dystrophy
Surgical History
- Prior cataract surgery (especially complicated phacoemulsification)
- Anterior chamber IOL implantation
- Glaucoma filtering surgery with tube near endothelium
- History of corneal graft (PKP, DSAEK, DMEK)
- Multiple intraocular procedures
Contact Lens–Related
- Extended or overnight contact lens wear
- Low-Dk (PMMA, conventional hydrogel) lens materials
- Poor lens hygiene and over-wear
- Scleral lens wear over compromised endothelium
Systemic and Ocular
- Recurrent herpetic eye disease (HSV / HZV keratouveitis)
- Chronic anterior uveitis
- Uncontrolled or acute angle-closure glaucoma
- Ocular hypertension with borderline endothelial reserve
- Advanced age (physiological endothelial cell attrition)
- Diabetes mellitus (accelerated endothelial cell loss)
Slit-lamp Biomicroscopy
- Corneal guttata (FECD): beaten-metal or drop-shaped excrescences on the posterior corneal surface visible on direct and retroillumination; central initially, spreading to periphery in advanced disease
- Epithelial microcysts: small grey-white intraepithelial vesicles in the basal epithelial layer; best seen on direct focal illumination or indirect retroillumination
- Epithelial bullae: larger fluid-filled intraepithelial or subepithelial blisters giving the corneal surface an irregular, cobblestone appearance; NaFl staining pooling confirms presence
- Stromal haze: diffuse grey-white ground-glass opacity of the stroma; reduces reflex from iris and makes posterior detail difficult to view
- Descemet membrane folds: fine wavy or irregular vertical folds visible in the posterior stroma and Descemet membrane on retroillumination; indicate stromal swelling
- Increased corneal thickness: the cornea appears optically thicker on slit-lamp optical section; confirmed by pachymetry
- Subepithelial fibrosis / pannus: grey-white subepithelial haze from fibrous tissue replacing bullous epithelium in chronic advanced disease
- Corneal neovascularisation: superficial vessels in chronic severe edema from prolonged inflammation or hypoxia
- Reduced corneal sensitivity: measurable by esthesiometry; occurs in herpetic and chronic edematous corneas
Specular Microscopy Findings
- Reduced endothelial cell density (ECD <1000 cells/mm² is high risk; <500 cells/mm² is critical)
- Increased coefficient of variation (CV >30% = polymegethism) — cells varying markedly in size
- Increased percentage of hexagonal cells below 50% (pleomorphism)
- Guttata appear as dark, non-reflecting areas interrupting the endothelial mosaic
Symptoms of corneal edema correlate directly with the degree of fluid accumulation and the stage of disease. The characteristic pattern of morning blur that improves through the day is virtually pathognomonic of corneal edema and reflects nocturnal accumulation of fluid under the closed-eye environment (reduced evaporative tear loss, elevated corneal temperature) that partially resolves as the eye opens and evaporation recommences.
- Blurred or hazy vision: worse on waking; improves within 1–2 hours in early-to-moderate edema; persistent in advanced disease
- Glare and halos: light scatter from disrupted lamellar spacing produces haloes around lights, particularly at night; often the first functional complaint
- Reduced contrast sensitivity: may precede measurable Snellen acuity reduction, particularly in Fuchs dystrophy
- Photophobia: mild in stromal edema; marked in bullous keratopathy with exposed nerve endings
- Ocular pain and foreign body sensation: mild discomfort in stromal edema; acute, severe, stabbing pain when a bulla ruptures — one of the most painful experiences in ophthalmic practice
- Epiphora: reflex tearing in response to corneal surface irregularity or pain from ruptured bullae
- Monocular diplopia / ghost images: irregular corneal surface from bullae and haze produces multiple focal points
Clinical note: Morning blur improving through the day in a patient over 50 is a hallmark of Fuchs dystrophy until proven otherwise. Always ask about diurnal variation in vision quality during history-taking.
Bullous Keratopathy and Corneal Pain
Repeated cycles of bulla formation and rupture cause severe acute pain, significantly impairing quality of life. Pain arises from exposure of subepithelial nerve plexus fibres when the epithelium overlying a bulla ruptures. Healing is followed by further bulla formation in an ongoing painful cycle. Even in patients with poor visual prognosis, pain management (bandage contact lens, amniotic membrane) is a primary treatment goal.
Subepithelial Fibrosis
Chronic repeated epithelial bullae and ruptures stimulate anterior keratocytes to produce collagen, forming a grey-white subepithelial fibrous panel. Paradoxically, this fibrous layer may reduce pain by insulating corneal nerves but significantly worsens visual prognosis by adding irreversible scarring to the optical axis.
Infectious Keratitis
Disrupted epithelial barrier from ruptured bullae creates a portal of entry for bacterial, fungal, and acanthamoeba pathogens. Infectious keratitis superimposed on bullous keratopathy is a vision-threatening complication that can progress rapidly to corneal perforation. Any new infiltrate, discharge, or worsening pain in a patient with bullous keratopathy requires urgent evaluation.
Corneal Vascularisation
Chronic hypoxia and inflammation stimulate superficial and deep stromal neovascularisation. Vessels in the optical zone permanently degrade vision and complicate future corneal transplantation by increasing the risk of immune rejection.
Permanent Scarring and Visual Loss
If corneal edema is untreated or progresses beyond the endothelial transplant window, irreversible stromal scarring, subepithelial fibrosis, and superficial pannus formation can permanently compromise vision even after surgical correction of the underlying cause.
Diabetes Mellitus
Diabetic patients have a significantly higher rate of endothelial cell loss both from the disease itself (sorbitol accumulation, advanced glycation end-products altering endothelial cell function) and from surgical insult — diabetic corneas are measurably more vulnerable to phacoemulsification-induced endothelial cell loss. Pre-operative endothelial cell count and pachymetry are particularly important in diabetic patients scheduled for cataract surgery.
Systemic Autoimmune Disease
Rheumatoid arthritis, SLE, and ankylosing spondylitis are associated with anterior uveitis — a major cause of inflammatory corneal edema. Chronic or recurrent uveitis directly damages endothelial cells through cytokine-mediated apoptosis. Systemic immunosuppression for these conditions (corticosteroids, methotrexate, biologics) may reduce uveitis frequency and thereby protect endothelial cell reserves.
Herpes Simplex and Herpes Zoster
Recurrent HSV keratouveitis causes progressive endothelial cell loss through direct viral cytopathic effects and immune-mediated endotheliitis. Herpes zoster ophthalmicus (HZO) affects the endothelium through similar mechanisms, often with more severe inflammation. Antiviral prophylaxis (aciclovir 400 mg twice daily) in high-risk patients reduces recurrences and consequent endothelial damage.
Fuchs Dystrophy and TCF4 Gene Mutation
Fuchs endothelial corneal dystrophy has a well-characterised genetic basis. Trinucleotide repeat expansion in the TCF4 gene accounts for approximately 70% of FECD cases in Europeans. The SLC4A11, ZEB1, LOXHD1, and AGBL1 genes are implicated in less common variants. First-degree relatives of FECD patients warrant slit-lamp screening and specular microscopy, particularly before elective intraocular surgery.
Exfoliation Syndrome
Pseudoexfoliation syndrome is associated with reduced corneal endothelial cell density and higher rates of pseudophakic corneal edema after cataract surgery. Exfoliative material deposits on the corneal endothelium and may directly impair pump function. Surgeons should exercise particular care with phacoemulsification in pseudoexfoliation eyes with borderline endothelial counts.
Clinical Assessment
- Best-corrected visual acuity: document at each visit; morning versus afternoon comparison is diagnostically valuable in FECD
- Slit-lamp biomicroscopy: assess epithelium (bullae, microcysts), stroma (haze, vascularisation), Descemet membrane (folds, guttata), endothelium (beaten-metal reflex); use retroillumination for subtle Descemet folds and guttata
- Fluorescein staining: pooling in bullous epithelium; rose bengal / lissamine green for compromised epithelium
- IOP measurement: applanation tonometry (Goldmann); note that corneal edema artificially lowers IOP readings; correct for pachymetry
- Corneal sensitivity: Cochet-Bonnet esthesiometry — reduced in herpetic disease and chronic edema
Corneal Pachymetry
Central corneal thickness (CCT) measured by optical coherence tomography-based pachymetry (AS-OCT), Pentacam/Scheimpflug, or ultrasound pachymetry is the objective measure of edema severity. Normal CCT is 520–540 µm (central); values above 600 µm indicate significant edema; above 700 µm represents severe bullous keratopathy. Serial pachymetry monitors disease progression objectively.
Specular Microscopy
Non-contact specular microscopy quantifies endothelial cell density (cells/mm²), cell morphology (hexagonality, polymegethism), and documents guttata as dark areas. It is essential for pre-operative assessment before any intraocular surgery, for monitoring Fuchs dystrophy progression, and for post-operative follow-up after endothelial keratoplasty. In severe edema, specular microscopy may be technically difficult due to corneal haze.
Anterior Segment OCT (AS-OCT)
AS-OCT provides high-resolution cross-sectional imaging of all corneal layers, allowing measurement of individual epithelial and stromal thickness, identification of subepithelial fluid, and characterisation of Descemet membrane. Particularly useful for monitoring epithelial thickness maps in FECD and for evaluating graft-host interface after endothelial keratoplasty.
Confocal Microscopy
In-vivo confocal microscopy (IVCM) provides cellular-level imaging of all corneal layers including real-time endothelial cell morphology, keratocyte density, and detection of inflammatory cells, pathogens (herpetic dendrites, acanthamoeba cysts), and guttata with greater detail than specular microscopy. It is a valuable adjunct for complex or atypical cases.
Posterior Segment Assessment
Posterior segment evaluation using approved non-dilating diagnostic equipment is essential to exclude concurrent glaucomatous optic neuropathy (particularly in ICE syndrome and post-surgical cases) and to assess the vitreoretinal status before surgical planning. When corneal haze precludes adequate non-dilating assessment, referral to ophthalmology for dilated examination or ultrasound B-scan is indicated.
Singapore Optometry Scope Note: Optometrists can monitor corneal edema clinically using slit-lamp biomicroscopy, pachymetry, and specular microscopy, and provide supportive management with hyperosmotic agents and lubricants. Posterior segment assessment should use approved non-dilating diagnostic equipment; dilated fundus examination is not within Singapore optometry scope of practice. Optometrists cannot prescribe topical corticosteroids, NSAIDs, or antiviral medications. Any corneal edema with progressive VA loss, bullae, suspected infectious keratitis, or requiring surgical evaluation must be referred to an ophthalmologist. Contact lens modification for hypoxic edema (upgrading to high-Dk silicone hydrogel, reducing wear time) is within scope.
1. Treat Underlying Cause
- Acute angle closure: emergency IOP lowering (IV acetazolamide, topical beta-blockers, pilocarpine, laser peripheral iridotomy) — edema resolves rapidly with IOP normalisation
- Herpetic endotheliitis: systemic antiviral (aciclovir/valaciclovir) plus topical corticosteroid under ophthalmology supervision
- Uveitic: aggressive anti-inflammatory treatment; IOP control
- Contact lens hypoxia: cease extended wear; switch to daily wear silicone hydrogel; reduce total wearing time; edema typically reverses within days to weeks
- IOL-touch: IOL repositioning or exchange surgery
2. Hyperosmotic Agents (Conservative)
Hyperosmotic agents are available without prescription in some formulations; however, prescription-strength preparations require ophthalmologist or GP initiation. Optometrists in Singapore cannot prescribe prescription-only hyperosmotic agents.
- Sodium chloride 5% eye drops (Muro 128): osmotically dehydrates the corneal epithelium; typically used 3–4 times daily; improves morning vision in mild-moderate FECD; available OTC in some countries
- Sodium chloride 5% ointment: used nightly for nocturnal corneal dehydration; particularly useful in early FECD with diurnal variation
- Hair dryer technique: patients with FECD may use a cool setting hairdryer at arm's length to reduce morning corneal hydration — a simple non-pharmacological manoeuvre with established efficacy
3. Bandage Contact Lens (BCL)
Silicone hydrogel extended-wear bandage contact lenses provide a physical barrier protecting exposed corneal nerves in bullous keratopathy, dramatically reducing pain from bulla rupture. BCLs do not improve vision or reverse edema; their role is palliative pending surgical intervention. Monitor closely for infectious keratitis given the compromised epithelial barrier. Fitting and monitoring of BCLs is within optometry scope; prescribing topical prophylactic antibiotics to accompany BCL wear requires ophthalmological prescription.
4. Surgical Management (Ophthalmology)
All surgical interventions are performed by ophthalmologists. Optometrists play a critical role in pre-operative counselling, post-operative monitoring, and identifying deterioration requiring re-referral.
| Procedure | Indication | Key Advantage |
|---|---|---|
| DMEK (Descemet Membrane Endothelial Keratoplasty) | FECD, PBK with good stroma | Best visual outcomes (>6/9 in majority); low rejection rate; faster recovery |
| DSAEK (Descemet Stripping Automated Endothelial Keratoplasty) | PBK, FECD, complex cases with anterior chamber abnormalities | More surgically forgiving than DMEK; good visual outcomes; selective endothelial replacement |
| Penetrating Keratoplasty (PKP) | Full-thickness corneal scarring; failed EK; anterior + posterior pathology | Treats all layers simultaneously; appropriate for combined pathology |
| Amniotic Membrane Transplantation (AMT) | Palliative pain relief in bullous keratopathy; poor surgical candidates | Reduces pain; promotes re-epithelialisation; no visual recovery |
| Descemetorhexis Without Endothelial Keratoplasty (DWEK) | Central FECD guttata with peripheral endothelial reserve | Stimulates peripheral endothelial migration; no donor tissue needed; experimental |
5. Emerging Therapies
- ROCK inhibitor eye drops (Y-27632, ripasudil): promote endothelial cell proliferation and migration; showing promise in post-DWEK and early FECD in phase II/III trials
- Cultivated endothelial cell injection: injection of ex-vivo expanded human corneal endothelial cells into the anterior chamber; promising results in early clinical studies in Japan
- Gene therapy: targeting TCF4 repeat expansion in FECD with antisense oligonucleotides (AON) — preclinical stage
Reversible Causes
Corneal edema from contact lens hypoxia is fully reversible on lens removal, typically resolving within hours to days. Acute angle closure-induced edema clears rapidly with effective IOP lowering if endothelial cells have not been irreversibly damaged by the pressure episode. Mild inflammatory edema from anterior uveitis or herpetic disease can resolve completely with appropriate anti-inflammatory and antiviral treatment.
Fuchs Endothelial Dystrophy
FECD is a slowly progressive condition over decades. The majority of patients manage well with conservative measures (hypertonic saline, avoidance of prolonged hot shower steam) for years before vision deteriorates to a surgical threshold. DMEK now offers excellent outcomes with more than 80% of operated eyes achieving BCVA of 6/9 or better. Graft survival at 5 years exceeds 90% for FECD, the best indication for endothelial keratoplasty.
Pseudophakic Bullous Keratopathy
PBK carries a more variable prognosis depending on the extent of associated anterior segment pathology, presence of corneal scarring, and state of the drainage angle. DSAEK achieves BCVA of 6/12 or better in 60–75% of PBK eyes, lower than in FECD due to more frequent concomitant pathology. Graft survival at 5 years is approximately 70–80%.
Prognostic Factors
Favourable
- Reversible aetiology (CL, IOP)
- No corneal vascularisation
- No subepithelial fibrosis
- FECD without stromal scarring
- Early referral and intervention
Unfavourable
- Dense stromal scarring / fibrosis
- Corneal neovascularisation
- Concurrent glaucoma or angle pathology
- Failed prior graft
- Infectious keratitis superimposition
| Condition | Key Distinguishing Features |
|---|---|
| Corneal Scar / Leucoma | White, dense, non-oedematous opacity; normal pachymetry; no Descemet folds; stationary; history of trauma, infection, or surgery |
| Corneal Dystrophies (Stromal) | Lattice, macular, granular dystrophies — discrete opacities with specific patterns; normal endothelium; no diurnal fluctuation in vision; bilateral symmetric; confirmed by genetics |
| Corneal Infiltrate / Ulcer | Focal white cellular infiltrate with overlying epithelial defect; pain, discharge, photophobia; localised rather than diffuse haze; NaFl staining of epithelial defect |
| Keratoconus | Progressive thinning and ectasia; Fleischer ring, Vogt striae, apical scarring in advanced cases; normal endothelium; topography shows inferior steepening; does not cause diffuse stromal haze |
| Acanthamoeba Keratitis | Severe disproportionate pain; ring infiltrate; pseudodendrites; contact lens history; NaCl staining; perineural infiltrate on confocal microscopy; no diurnal VA variation |
| Interstitial Keratitis | Deep stromal vascularisation (ghost vessels); associated with syphilis, TB, herpes; salmon-patch appearance; deep stromal haze with vessels; no endothelial pump failure |
| Peter Anomaly / Sclerocornea | Congenital central corneal opacity with iris-corneal adhesions; present at birth; no progressive diurnal change; associated with systemic anomalies |
| Band Keratopathy | Horizontal grey-white calcium deposits in Bowman layer across the interpalpebral zone; associated with hypercalcaemia, chronic uveitis; chalky white, not grey haze; no Descemet folds |
- Diurnal fluctuation is the hallmark: morning blurring that improves by mid-morning is the single most discriminating symptom of corneal edema — specifically FECD. Always ask about the time-of-day pattern of vision quality change.
- Retroillumination reveals early guttata: subtle FECD guttata and Descemet folds are best appreciated on retroillumination — they are easily missed on direct focal illumination. Make retroillumination examination of the endothelium a routine in patients over 50.
- Screen FECD relatives before intraocular surgery: first-degree relatives of FECD patients should have pre-operative specular microscopy and pachymetry before any planned intraocular procedure — undiagnosed borderline endothelial reserve is the most preventable cause of pseudophakic bullous keratopathy.
- Pachymetry corrects IOP reading: corneal edema artificially depresses Goldmann applanation tonometry readings — in a thick oedematous cornea (>600 µm), the true IOP may be substantially higher than the measured value; always interpret IOP in the context of corneal thickness.
- Hair dryer is evidence-based: advising FECD patients to use a hair dryer on a cool setting at arm's length for a few minutes each morning has genuine efficacy in reducing morning oedema — a practical, cost-free, and side-effect-free adjunct to hypertonic saline.
- Bandage lens without antibiotic cover is high risk: fitting a bandage contact lens on bullous keratopathy without concurrent topical antibiotic prophylaxis (prescribed by ophthalmologist) significantly increases infection risk — always co-manage with ophthalmology when BCLs are needed for pain.
- DMEK is now the gold standard for FECD: inform patients with progressing FECD that modern endothelial keratoplasty (DMEK) has transformed outcomes — most achieve driving-standard vision, with rapid visual rehabilitation and very low rejection rates compared to historical full-thickness PKP.
- Contact lens hypoxia is still relevant: despite widespread adoption of silicone hydrogel lenses, corneal edema from overnight wear, lens overwear, or low-Dk lenses remains a real clinical finding — measure CCT and check endothelial health in any contact lens wearer with unexplained chronic VA reduction.
- Gain P, Jullienne R, He Z, Aldossary M, Acquart S, Cognasse F, et al. Global survey of corneal transplantation and eye banking. JAMA Ophthalmol. 2016;134(2):167-73.
- Bourne WM. Biology of the corneal endothelium in health and disease. Eye (Lond). 2003;17(8):912-8.
- Koeppe L. Klinische Beobachtungen mit der Nernstspaltlampe und dem Hornhautmikroskop. Graefes Arch Clin Exp Ophthalmol. 1916;91:363-79.
- Wiffen SJ, Maguire LJ, Bourne WM. Fuchs corneal dystrophy. Semin Ophthalmol. 1997;12(1):2-8.
- Mootha VV, Gong X, Ku HC, Xing C. Association and familial segregation of CTG18.1 trinucleotide repeat expansion of TCF4 gene in Fuchs endothelial corneal dystrophy. PLoS One. 2014;9(9):e106382.
- Deng SX, Lee WB, Hammersmith KM, Kuo AN, Li JY, Shen JF, et al. Descemet membrane endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology. Ophthalmology. 2018;125(2):295-310.
- Price MO, Giebel AW, Fairchild KM, Price FW Jr. Descemet membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival. Ophthalmology. 2009;116(12):2361-8.
- Terry MA, Shamie N, Chen ES, Hoar KL, Friend DJ. Endothelial keratoplasty: a simplified technique to minimize graft dislocation, iatrogenic graft failure, and postoperative astigmatism. Ophthalmology. 2008;115(7):1179-86.
- Lass JH, Gal RL, Dontchev M, Beck RW, Kollman C, Dunn SP, et al. Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation: Specular Microscopy Ancillary Study results. Arch Ophthalmol. 2008;126(11):1486-94.
- Forstot SL, Damiano RE. Trauma and Fuchs' endothelial dystrophy. Ophthalmology. 1988;95(4):487-90.
- Wilson SE, Bourne WM, Brubaker RF. Effect of desmopressin on corneal endothelial function in Fuchs' dystrophy. Invest Ophthalmol Vis Sci. 1988;29(10):1538-42.
- Thoft RA, Friend J. Biochemical transformation of regenerating ocular surface epithelium. Invest Ophthalmol Vis Sci. 1977;16(1):14-20.
- Laing RA. Specular microscopy of the corneal endothelium: optical principles and clinical applications. Dev Ophthalmol. 1981;4:1-74.
- Holden BA, Mertz GW. Critical oxygen levels to avoid corneal edema for daily and extended wear contact lenses. Invest Ophthalmol Vis Sci. 1984;25(10):1161-7.
- Efron N. Grading scales for contact lens complications. Ophthalmic Physiol Opt. 1998;18(2):182-6.
- Tan DT, Dart JK, Holland EJ, Kinoshita S. Corneal transplantation. Lancet. 2012;379(9827):1749-61.
- Numa K, Ueno M, Kitazawa K, Hirano S, Hamuro J, Kinoshita S. Rho kinase inhibitor eye drops for the treatment of patients with corneal endothelial dysfunction. Cornea. 2020;39(5):634-9.
- Kinoshita S, Koizumi N, Ueno M, Okumura N, Imai K, Tanaka H, et al. Injection of cultured cells with a ROCK inhibitor for bullous keratopathy. N Engl J Med. 2018;378(11):995-1003.
- Bhogal M, Lwin CN, Seah XY, Peh G, Mehta JS. Allogeneic Descemet's membrane transplantation enhances corneal endothelial monolayer formation and restores functional integrity following Descemet's stripping. Invest Ophthalmol Vis Sci. 2017;58(10):4249-60.
- Kim BZ, Meyer JJ, Brookes NH, Moffatt SL, Twohill HC, Brunette I, et al. New Zealand trends in corneal transplantation over the 25 years 1991-2015. Br J Ophthalmol. 2017;101(6):834-8.